Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1998-01-09
1999-01-12
Nazario-Gonzalez, Porfirio
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
562623, A01N 3728
Patent
active
058590617
ABSTRACT:
The present invention provides a compound of formula I ##STR1## or pharmaceutically acceptable salts thereof wherein R.sup.1 and R.sup.2 are the same or different and are C.sub.1-10 alkyl, phenyl, hetero-aryl, or phenyl substituted with C.sub.1-4 alkyl, OR.sup.3, NHR.sup.3, CONHR.sup.3, NHCOR.sup.3, or halo; wherein R.sup.3 is H, or C.sub.1-4 alkyl; and n is 1, 2, 3, 4, 5, or 6. The compounds are inhibitors of matrix metalloproteinases involved in tissue degradation.
REFERENCES:
patent: 5506242 (1996-04-01), MacPherson et al.
patent: 5552419 (1996-09-01), MacPherson et al.
U.S. application Ser. No. 60/029,585, M. Warpehoski, et al., Oct. 23, 1996.
Jacobsen Eric Jon
Skaletzky Louis L.
Davis Brian J.
Nazario-Gonzalez Porfirio
Pharmacia & Upjohn Company
Yang Lucy X.
LandOfFree
Bis-sulfonamides hydroxamic acids as MMP inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bis-sulfonamides hydroxamic acids as MMP inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bis-sulfonamides hydroxamic acids as MMP inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1516523